Economy · Full coverage
Novolog Appoints New CEO Amid Major Leadership Changes and Ownership Consolidation
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Unrated 2
First reported by Globes · 2 hours ago
What happened
Novolog is replacing CEO Aviad Busi with Ze'ev Menzur amid major leadership shifts and ownership consolidation by the Pozis family. The company faces financial challenges including revenue declines, operational setbacks, and loss of key clients, while a rival investor seeks to take control.
- 01Novolog appoints Ze'ev Menzur as new CEO starting December 2026.
- 02CEO Aviad Busi and CFO Yaniv Vidavski are leaving amid ownership consolidation.
- 03Pozis family solidifies control after board overhaul and counters rival investor's bid.
- 04Novolog's 2025 revenue dropped 11% due to distribution system issues and geopolitical tensions.
- 05Adjusted EBITDA fell 12% in H1 2026; net profit declined sharply year-over-year.
- 06Novolog's stock value dropped from 1.8 billion to 378 million shekels since 2022.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Novolog CEO and CFO Resign Amid Ownership Shakeup Led by Pozis Family4 days agoOded Pozis Takes Control of Novolog, Appoints New Board Amid Ownership BattleAug 6, 2026Control Battle Erupts at Israeli Healthcare Firm Novolog Amid Share Decline and Investment OfferAug 3, 2026Novolog Control Battle Intensifies as Owner Seeks Board Dissolution Amid Movement's Buyout OfferJul 30, 2026Pazis Family Secures Control of Israeli Pharma Distributor Novolog After Boardroom BattleAug 16, 2026Pozis Family Vows Legal Fight and Possible Stake Increase in Novolog Control BattleJul 30, 2026